Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors

Author： Su H.

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.124, Iss.1, 2010-11, pp. : 205-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase Inhibitors for Treatment of Breast Cancer

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 67-79

Bentham Science Publishers

Access to resources Recommend Favorite

Postmenopausal breast cancer, androgens, and aromatase inhibitors

By Campagnoli C.

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase Inhibitors: Indications for Breast Cancer Therapy

By Assikis V.J.

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 93-100

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors in the treatment of early and advanced breast cancer

By Joensuu Heikki Ejlertsen Bent Lønning Per Rutqvist Lars-Erik

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 54-65

Bentham Science Publishers

Access to resources Recommend Favorite